Polaris Pharmaceuticals-KY (6550) Announces Key Resolutions from 2026 Annual General Meeting

Announcement Date: May 16, 2026 Date of Announcement: May 15, 2026 Time of Announcement: 21:15:06 Company Code: 6550 Company Name: Polaris Pharmaceuticals-KY Subject: Announcement of Important Resolutions from the Company's 2026 Annual General Meeting Compliance Clause: Clause 18 Date of Event: May 15, 2026 Description: 1. Date of Shareholder Meeting: May 15, 2026 2. Important Resolution I: Profit Distribution or Loss Compensation: Approval of the 2025 loss compensation proposal. 3. Important Resolution II: Amendment of Articles of Incorporation: None. 4. Important Resolution III: Business Report and Financial Statements: Approval of the 2025 business report and financial statements proposal. 5. Important Resolution IV: Election of Directors and Supervisors: Full re-election of the company's directors (independent directors). 6. Important Resolution V: Other Matters: (1) Proposal to lift non-compete restrictions for new directors and their representatives. (2) Approval of the company's proposed capital reduction to offset losses. (3) Amendment to the asset disposal procedures. (4) Amendment to the Rules of Procedure for Shareholder Meetings. 7. Other Matters to be Noted: None.